NEW YORK (GenomeWeb) – Genetic Technologies said it has raised A$18.6 million (US$14.3 million) after securing commitments from US investors. 

The Australian molecular diagnostics firm is offering 499,999,950 shares of its common stock, represented by 3,333,333 American Depositary Shares, with each ADS representing 150 ordinary shares of Genetic Technologies' shares. The firm is selling the securities directly to US investors. Maxim Group is the placement agent for the offering. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.